
Investornewsbreaks Kairos Pharma Ltd. (NYSE American: KAPA) Secures Dod Grant To Advance Lung Cancer Biomarker Research
(MENAFN- Investor Brand Network) Kairos Pharma (NYSE American: KAPA) , a clinical-stage biopharmaceutical company, issued a shareholder letter from CEO John Yu, M.D., outlining recent progress and strategic developments. The company is advancing two …